Latest News

Indian conglomerate buys Manhattan Research parent for $635m

May 16, 2012

A Mumbai-based pharma custom manufacturing firm is buying the parent company of Manhattan Research.
 

Sales forces shrank in 2011, but not everywhere

May 16, 2012

Pharmas shrank their US sales forces by 7% between 2010 and 2011, but the pain wasn't shared evenly between the biggest of pharmas, as a number of players scaled up.
 

National plan seeks Alzheimer's treatment by 2025

May 15, 2012

HHS Secretary Kathleen Sebelius released the National Plan to Address Alzheimer's Disease at the second day of the National Alzheimer's Research Summit Tuesday.
 

Coach vs. cancer in BMS-backed awareness effort

May 15, 2012

Former Steelers coach Bill Cowher is fronting a Bristol-Myers Squibb-backed Melanoma Exposed awareness campaign.
 

Wolters Kluwer deals health analytics unit to private equity firm

May 15, 2012

Symphony Technology Group, a private equity firm, acquired the healthcare analytics business of Wolters Kluwer, the companies said.
 

RX-to-OTC proposal gets mixed reviews

May 14, 2012

Industry and physician groups expressed wary support for the FDA's "new paradigm" drug proposal, which would create a nonprescription "Behind the Counter" class of drugs available through pharmacists.
 

Siding with Lilly, appeals court overturns decision in rep overtime case

May 10, 2012

The latest round of Sales Reps vs. Pharma has favored...the pharma industry. The Seventh Circuit Court of Appeals said that Eli Lilly did not owe former rep Susan Schaeffer-LaRose overtime.
 

Humira on solid ground, analysts say, despite vote on Pfizer hopeful

May 10, 2012

The general consensus surrounding the FDA advisory panel's 8-2 vote in favor of Pfizer's rheumatoid arthritis hopeful tofacitinib yesterday was that Abbott's Humira doesn't have to watch its back.
 

Makers of pain pills, advocacy groups at center of Senate probe

May 09, 2012

The Senate Finance Committee is looking to crack down on unnecessary pain prescriptions and is using a money trail to do it.
 

Saatchi shop rebrands to sharpen specialty focus

May 08, 2012

Saatchi & Saatchi Innovations, Publicis' Pennsylvania-based outpost servicing specialty pharma, is rebranding as Saatchi Science.
 

Agency Spotlight

Click here for MM&M’s guide to Healthcare Agencies

Latest Issue

Get Back in Shape
As pharma deals with old, expiring brands and not enough newcomers to replace them, we look at industry's regimen for regaining form. PLUS: How cutbacks are impacting CME, and some lessons on how to keep your focus on customers as well as products

The Interactive Guide

The Interactive Guide
In this special supplement to MM&M, you'll find plenty of trends, data, insights, tips and examples to help you make the most of digital opportunities.

Latest Features

Pharma Report 2012: Get Back in Shape

Med Ed Report: Show Me the Money

Product Communications: When Love Is Blind

MM&M Awards: Dream Team 2012

Headliner: Hayes' open-door policy opens doors

 Subscribe to the RSS for this page  [view all our RSS feeds here]

Video Exclusive

Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 

MM&M Awards 2011 HIghlights

The Best MM&M Awards Ever!

MAHF Ceremony 2012

Photos from the Medical Advertising Hall of Fame Awards ceremony
 
Popular Topics
Acquisition Adherence Agency App Conflict Of Interest Digital Direct To Consumer (DTC) Downsize Education & Awareness FDA Law Marketing Research Media Medical Journal Mobile Obesity Oncology Patients Physicians Rebranding Regulatory REMS Reputation Sales Force Samples